Stocks to Watch 06-03-09

STEADFAST HOLDINGS GROUP (OTC: STHG)
"Up 111.11% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/STHG.php

Steadfast Holdings Group distributes a variety of products to the automotive aftermarket. The core business is its spray on truck bed protection product which offers specially formulated polymers that permanently bond to the truck's bed. The Company's spray-on Polyurea is a remarkable technology with a range of uses limited only by your imagination. They are also utilized in commercial, industrial, agricultural, military and custom applications when this tough coating is used to protect everything from metals to concrete against chemicals, solvents, fuel, etc. The Company is a licensed dealer for the following aftermarket products: A.R.E. Truck Caps and Lids, Tool Boxes, Nerf Bars, Tube Steps, Running Boards, Rack Systems, Rail Caps, Tonneau Covers, Fender Flares, Grilles, Visors, Bug Shields, Roll-Up Covers, Side Rails, Mud Guards, Floor Mats, Lights, Trailer Hitches, Stainless Steel Accessories and Lift Kits. Steadfast also has distribution agreements with the several companies that manufacture light truck aftermarket products. Additional information may be found at www.steadfastlinings.com.

STHG News:

June 2 - Stratton Holdings' CEO Announces Plan to Reduce Outstanding Shares by 23%

Stratton Holdings, Inc. (OTC: STHG) released the following update on its operations:

Chief Executive Officer, Mr. Eric Stratton Racheff, wanted to inform shareholders of his decision:

"In taking a look at the overall picture of the Company's goals and the Company's share structure I have decided to cancel 100,000,000 shares of my personal holdings. Of which I will instruct our Transfer Agent to do so for an execution date of Monday, June 15th, 2009.

"The reason for this is very simple, our ideal share structure is much lower than it is now. We also are building a group each taking on ownership and that includes investors. Rather than the all too common Pinksheet company where the CEO owns 95%. This will change that and allow us to move forward

"Here is the current share structure as of June 1st 2009:

"Outstanding Shares: 424,075,777

"Held by Insiders: 234,000,000

"I feel this is a correct step for not only me but for the Company as who wants to secure financing in such a low range.

"Another thing I wanted to address was the Caveat Emptor that Pinksheets LLC. has marked our company with. I wanted to let shareholders know that this is a policy of Pinksheets LLC that if a company executes a name change then they need to provide financials accepted by the Securities and Exchange Commission or otherwise get marked with Caveat Emptor. I have spoken with the Securities Exchange Commission and we now know what is needed to begin filing with the SEC. As of right now we can't file with them, hence no form 3s,4s,8-ks etc. But the Company is working towards handling this and providing the needed information to the SEC as well as Pinksheets LLC.

We continue to have many things cooking for the Summer of 2009 and I look forward to announcing some additional major events."

VIPR INDUSTRIES INCORPORATED (OTC: VIPR)
"Up 50.00% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/VIPR.php

VIPR Industries, Inc. offers construction and mining services. It owns and operates gold and uranium mines in Tanzania and Democratic Republic of the Congo. The company, formerly known as Synergy Media, Inc. is headquartered in Toronto, Canada.

VIPR News:

May 28 - VIPR Industries Provides Corporate Update

VIPR Industries Inc. (OTC: VIPR) ("VIPR") announces update on funding and projects.

Within the past quarter, VIPR Industries (the "Company") has received funding in various tranches and sizes from accredited investors with the expectations of further funds being received. The company is currently evaluating all options as it anticipates using most of its cash reserves towards further exploration on existing assets and possible acquisitions. In its most recent press release, the company indicated that it was attempting to identify further target zones for further exploration on its Singida-Londoni property in Tanzania. This information is currently being reviewed by the company and Geologists which also includes a budget brought forth towards the drafting of a possible NI 43-101 report on its Singida-Londoni property.

In addition, VIPR's Chief Operating Officer and Chief Geologist has recently brought to the attention of the company other potential acquisitions that may be in more advanced stages or possess significant potential. These prospective projects are located in other parts of the world, most notably within certain parts of South America where various countries are expected to have an estimated $40 Billion in exploration to be spent within the next several years. The Company expects a decision on its various options to be concluded in the very near term. In other developments, a recent proposal was made by VIPR to further its current position at the Mwamunguli Diamond Prospect. The offer was not accepted by the current license holder.

CANARGO ENERGY CORPORATION (OTC: CANR)
"Up 47.50% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/CANR.php

CanArgo is an independent oil and gas exploration and production company with its oil and gas operations currently located in Georgia.

CANR News:

May 31 - CanArgo Energy Corporation Reports 2009 First Quarter Results

CanArgo Energy Corporation (OTC: CANR) (Oslo: CNR.OL) ("CanArgo" or the "Company") reported results for the three months ending March 31, 2009.

Operating Revenues from Continuing Operations for the three month period ended March 31, 2009 deteriorated to $1.5 million from $2.6 million for the corresponding period for 2008. This deterioration was attributable to a decrease in the realised price for oil sold at the Ninotsminda Field in Georgia despite there being higher volumes of oil sold.

The Company reported net income for the three month period ended March 31, 2009 of $1.9 million compared to a net loss of $1.2 million in the corresponding period for 2008. This was attributable to the Company recording Total Other Income of $2.9 million compared to Total Other Expense of $1.0 million for the corresponding period for 2008. The improvement in net income attributable to Total Other Income was offset partially by an increased Operating Loss from Continuing Operations.

Operating Loss from Continuing Operations for the three month period ended March 31, 2009 increased to $1.0 million compared to an Operating Loss of $0.2 million in the corresponding period for 2008. This was due to the deterioration in Operating revenues from Continuing Operations, increased Field Operating Expenses and Direct Project Costs offset partially by reduced Selling, General and Administrative Expenses and reduced Depreciation, Depletion and Amortization.

Total Other Income for the three month period ended March 31, 2009 of $2.9 million included a $3.9 million gain in Settlement of Accounts Payable. This gain was attributable to a Settlement Agreement that the Company entered into on February 9, 2009 with WEUS Holding Inc ("WEUS") a subsidiary of Weatherford International Ltd as reported previously.

The information set forth herein and in the exhibit is preliminary in nature, has been prepared by management and has not been reviewed or audited by the Company's auditors. Accordingly, such information does not necessarily reflect results of the Company's operations and financial condition that may be reportable after completion of a review or audit and, while management is reasonably confident that such information is materially accurate, such preliminary results may be subject to change and should not be regarded as a definitive report on results of operations and financial condition of the Company as at March 31, 2009 and as at December 31, 2008 and for the fiscal year then ended. Although these statements have been produced on a best effort basis and management believes they are accurate, they may not be relied upon.

As previously reported, the Company is currently in default in making interest payments under its outstanding Senior Subordinated Convertible Guaranteed Notes, due September 1, 2009 and its 12% Subordinated Convertible Guaranteed Notes, due June 28, 2010. The Company is continuing its negotiations with certain of the Note holders with a view to addressing such defaults. The Company is also currently in default under the terms of its Settlement Agreement with WEUS and is in discussions to resolve this default as well. There can be no assurance, however, that such negotiations and discussions will be successfully concluded.

LA JOLLA PHARMACEUTICAL COMPANY (NASDAQ: LJPC)
"Up 30.07% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/LJPC.php

La Jolla Pharmaceutical Company is dedicated to improving and preserving human life by developing innovative pharmaceutical products. The Company's leading product in development is Riquent®, which is designed to treat lupus renal disease by preventing or delaying renal flares. Lupus renal disease is a leading cause of sickness and death in patients with lupus. The Company has also developed potential small molecule drug candidates to treat various other autoimmune and inflammatory conditions.

LJPC News:

April 24 - La Jolla Pharmaceutical Files Form 8-K with SEC

Item 2.05

Costs Associated with Exit or Disposal Activities

As previously announced, La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the "Company") ceased the development of Riquent following a determination in February 2009 that the continuation of the ASPEN clinical trial would be futile. As a result of the decision to abandon the Riquent program, and in an effort to cut ongoing operating expenses, the Company terminated approximately 75 employees on April 20, 2009. Following this reduction in force and the termination of Riquent development activities, the Company is focusing its efforts on maximizing the value of its remaining assets, including its SSAO program, and is considering strategic transactions. As a result of the reduction in force, the Company expects to record a one-time charge of approximately $1.2 million in the quarter ending June 30, 2009.

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

In connection with the Company's efforts to reduce ongoing operating expenses, as described above in Item 2.05, the employment of the following executives of the Company was terminated as of April 20, 2009: Niv E. Caviar, Executive Vice President, Chief Business & Financial Officer; Michael J.B. Tansey, M.D., Ph.D., Executive Vice President, Chief Medical Officer; and Josefina T. Elchico, Vice President, Quality Operations.

Following the departure of Mr. Caviar, Gail A. Sloan, Vice President of Finance, will serve as the Company's principal financial officer and will continue to serve as the Company's principal accounting officer.

CHINA CABLECOM HOLDINGS LIMITED (NASDAQ: CABL)
"Up 34.21% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/CABL.php

China Cablecom is a joint-venture provider of cable television services in the People's Republic of China, operating in partnership with a local state-owned enterprise ("SOE") authorized by the PRC government to control the distribution of cable TV services through the deployment of analog and digital cable services. In June 2008, China Cablecom consummated an agreement to acquire a 60 percent economic interest in a cable network in Hubei province with paying subscribers exceeding 800,000. The Company originally acquired operating rights of the Binzhou Broadcasting network in Binzhou, Shandong Province in September 2007 by entering into a series of asset purchase and services agreements with a company organized by SOEs, owned directly or indirectly by local branches of State Administration of Radio, Film and Television in five different municipalities to serve as a holding company of the relevant businesses. China Cablecom now operates 28 cable networks with over 1.4 million paying subscribers. China Cablecom's strategy is to replicate the acquisitions by operating partnership models in other municipalities and provinces in the PRC and then introducing operating efficiencies and increasing service offerings in the networks in which it operates.

CABL News:

May 11 - China Cablecom Provides Update on Notice of Default

China Cablecom Holdings, Ltd. (Nasdaq: CABL) ("China Cablecom" or the "Company") issued a status update regarding a previously announced notice of default received from one of the lenders to its subsidiary, China Cablecom Limited (the "Borrower"), relating to principle and interest obligations of approximately $2.2 million due on April 19, 2009.

Based on the fact upon the above due date, the Company sought tolling agreements from all of the holders of the promissory notes issued in connection with the $20.0 million bridge financing that preceded the Company's merger with Jaguar Acquisition Corporation that funds consisting of outstanding principal amount together with any unpaid and accrued interest (aggregating to approximately $11.0 million on the due date, including the approximate $2.2 million owed to the lender mentioned above), had been made available in a separate fund during the process of arranging for the conversion of Renminbi in China. While most lenders provided such tolling agreements, they were only effective until April 30, 2009 and as of today, the full amount of principal, interest and penalty provisions are now due and payable.

During the course of discussions with the holders of these promissory notes, on the other hand, such holders expressed to the Company a strong preference to have the Company restructure its debt obligations of its joint venture partners with the Hubei state-owned enterprise in order to better reflect the current economic environment and the anticipated cash flows of the Company's cable television business. Accordingly, as of the date hereof none of such lenders have commenced action against the Borrower, based in part on the expectation that a comprehensive debt restructuring package will be proposed for their approval in the coming weeks.

HEMISPHERX BIOPHARMA INCORPORATED (AMEX: HEB)
"Up 33.33% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/HEB.php

Hemispherx Biopharma, Inc. is a specialty pharma company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection(r) (FDA approved for a category of sexually transmitted diseases) and the experimental therapeutics Ampligen(r) and Oragens(r). Ampligen(r) and Oragens(r) represent experimental RNA nucleic acids being developed for globally important debilitating diseases and disorders of the immune system. Hemispherx's platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has in excess of 50 issued patents comprising its core intellectual property estate and a fully commercialized product (Alferon N Injection(r)). The Company wholly owns and exclusively operates a GMP certified manufacturing facility in the United States for commercial products.

HEB News:

June 1 - Hemispherx Biopharma Presents Influenza Prevention / Treatment Platform at International Conference in Rome under Auspices of Italian Government

Company Accelerates Collaborations with Governmental, Academic and Pharmaceutical Groups to Prevent Pandemic Influenza

Hemispherx Biopharma (Amex: HEB) announced an invitation, funded entirely by the government of Italy, to present its technology platform for influenza control, at the upcoming "International Conference on Biotechnologies and Finance" in Rome on June 4-5, 2009, at the Sheraton Parco de Medici. According to the Conference Organizers, leaders of "private and public research centers, intellectual property holders and financial experts from Europe, Australia, Canada, Estonia, Singapore and the USA" will participate. Hemispherx will present in a Round Table Discussion on Pandemic Influenza, moderated by Dr. Elemer Piros, Senior Pharmaceutical Analyst at Rodman and Renshaw, a USA investment bank.

Hemispherx has a broad-based technology platform for confronting the potential of an influenza pandemic, which consists of both preventative (vaccine) components as well as experimental therapeutic interventions. Clinical results from trials conducted in Australia are being evaluated and major vaccine initiatives in Japan are being accelerated in collaboration with the Japanese National Institutes of Health and the Japanese Ministry of Health.